Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Genetic and clinical predictors of treatment response in depression.

Trial Profile

Genetic and clinical predictors of treatment response in depression.

Phase of Trial: Phase III

Latest Information Update: 08 Jun 2016

At a glance

  • Drugs Citalopram (Primary) ; Reboxetine (Primary)
  • Indications Major depressive disorder
  • Focus Pharmacogenomic; Therapeutic Use
  • Acronyms GENPOD
  • Most Recent Events

    • 22 Dec 2011 Results published in the British Journal of Psychiatry.
    • 22 May 2008 Results are expected to be reported in September 2008, according to the study protocol published in Trials.
    • 24 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top